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We investigated the accuracy of a single photon emission computed tomography (SPECT) system in quantifying a wide range
of radioactivity concentrations using diﬀerent scan times in both phantom and animal models. A phantom containing various
amounts of In-111 or Tc-99m was imaged until the activity had decayed close to background levels. Scans were acquired for
diﬀerent durations, employing diﬀerent collimator pinhole sizes. VOI analysis was performed to quantify uptake in the images
and the values compared to the true activity. The phantom results were then validated in tumour-bearing mice. The use of an
appropriate calibration phantom and disabling of a background subtraction feature meant that absolute errors were within 12%
of the true activity. Furthermore, a comparison of in vivo imaging and biodistribution studies in mice showed a correlation of 0.99
for activities over the 200kBq to 5MBq range. We conclude that the quantitative information provided by the NanoSPECT camera
is accurate and allows replacement of dissection studies for assessment of radiotracer biodistribution in mouse models.
1.Introduction
Invivoimagingofradiopharmaceuticaluptakebysinglepho-
tonemissiontomography(SPECT)insmallanimalmodelsis
animportanttoolwithgreatpotentialforthedevelopmentof
new and improved radiopharmaceutical agents for targeted
diagnosis and therapy of cancer [1–3]. In addition to
providing high-quality images for qualitative interpretation,
accurate quantiﬁcation is required to determine the amount
of uptake in tissues of interest and the pharmacokinetics of a
compound in vivo [4]. SPECT studies are advantageous as
they reduce the number of animals required compared to
necropsy studies and allow longitudinal studies in the same
animal [5].
Radionuclide imaging techniques such as SPECT and
positron emission tomography (PET) are widely used for
preclinical radiopharmaceutical development [6, 7]b e c a u s e
of the possibility of direct translation of results from
preclinicallaboratoriestothehumanclinicalsetting[8].PET
imaging has been seen as the more accurately quantiﬁable
techniqueduetoitshighersensitivity;however,development
of SPECT imaging systems in recent years has led to higher
resolution and sensitivity capabilities, making it an attractive
option for quantitative in vivo imaging using longer-lived
gamma-emitting radionuclides [8].
Three types of radionuclide quantiﬁcation study are
described in the literature. The ﬁrst is a semiquantitative
comparison of diﬀerent regions of the image such as
measurement of target-to-background uptake. The second is
quantiﬁcation of physiologic parameters such as perfusion
rate in dynamic studies. The third type, and the focus of this
paper, is absolute physical quantiﬁcation, the measurement
of the absolute activity concentration found in a volume-of-
interest (VOI) [6, 9]. A number of physical quantities inﬂu-
ence the absolute quantiﬁcation of SPECT images. These
include photon attenuation, scatter, and partial volume
errors [9].
Forrer et al. [10] previously found quantiﬁcation in vivo
using the SPECT imaging system to be highly accurate.
However, they injected approximately 50MBq of their
compound into each animal with a minimum uptake in the
organ of interest of 0.74% injected dose per gram (%ID/g)
giving an amount of activity in the target organ of around
1.4MBq. We were interested in exploring the quantiﬁcation2 International Journal of Molecular Imaging
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Figure 1: (a) Phantom used in imaging studies. The 3 microcentrifuge tubes were mounted in the centre of a polystyrene holder. The three
activity concentrations were approximately 20, 10 (In111)/5 (Tc99m), and 1MBq/250μL. (b) Reconstructed image slices with volume-of-
interest drawn in the transaxial plane highlighted in green.
accuracy further by trying to quantify even lower levels of
activity. The administered activity of a radionuclide that
mustbeusedforananimalimagingstudylargelydependson
its speciﬁc activity, the radiolabelling eﬃciency, and purity
of the compound and can range from approximately 1 to
50MBq. Uptake in organs of interest typically varies from <1
to 30% [1, 11]. Consequently, there is a need to determine
the validity of the measurements from SPECT imaging when
workingwithlowinjectedactivitiesandlowuptakeinorgans
of interest.
Our aim was to determine the accuracy of the Nano-
SPECT/CT preclinical imaging system for achieving absolute
quantiﬁcation data with both high and low activity con-
centrations and to use the results in protocol design for
future experiments. We investigated the minimum activity
concentration and acquisition duration required to collect
enough count statistics for accurate quantitative data by
performing phantom and in vivo studies. This information
can in turn determine required animal imaging times and
subsequently will inﬂuence experimental design.
2.MaterialsandMethods
2.1. Imaging Studies. The NanoSPECT/CT preclinical imag-
ing camera (Bioscan, Inc., Washington DC) is a 4-head
gamma camera which also incorporates a cone beam CT
imaging system. In order to provide high levels of sensitivity
and spatial resolution, multi-pinhole collimators are used.
For this study, two sets of collimators were tested with
pinhole sizes of 1.4mm and 2mm. Both collimator sets had
aﬁ e l do fv i e wo f3 0× 16mm and consisted of 9 pinholes
per head. The sensitivities of the pinhole collimators are
approximately >2200cps/MBq and >3500cps/MBq with a
resolution of ≤1mmor≤1.45mm for the 1.4mm and 2mm
apertures, respectively.
The use of multiple pinholes results in multiple over-
lapping projections, thus making full use of the detector
surface available and maximising sensitivity. However, the
nature of these projections means that it is not possible
t ou s eF i l t e r e dB a c kP r o j e c t i o na sam e a n so ft o m o g r a p h i c
image reconstruction. Hence, an Ordered-Subsets Expec-
tation Maximisation (OSEM) algorithm [12]i su s e df o r
all tomographic reconstructions. This algorithm does not
include any correction for either attenuation or scatter.
Images are not reconstructed with units of radioactivity
concentration per se. A conversion from dimensionless
image count values to units of radioactivity concentration in
megabecquerel is made by the InVivoScope analysis software
(supplied with the camera) incorporating a user deﬁned
calibration factor stored within the software. Calibrations
must be made for each radionuclide-aperture combination
as required.
The camera was calibrated for In-111 and Tc-99m for
both 1.4mm and 2mm apertures using a syringe ﬁlled
with a known concentration of activity previously measured
in a dose calibrator (VD 404, Veenstra, the Netherlands).
The time of the measurement was also noted. Since dose
calibrators are known to be less accurate at low activity
levels we measured the calibration syringe with high activity,
approximately 50MBq and a known volume (measured by
weight) of In-111 or Tc-99m.
Thesyringewasimagedacquiringaminimumof100,000
counts per frame and the scan was reconstructed using the
OSEM reconstruction algorithm with a 35% Gaussian ﬁlter
(this is the manufacturer’s description of the FWHM of the
Gaussian ﬁlter) applied to the 2D projection data to reduce
noise, 9 iterations, and a 0.4mm voxel size. To mimic the
attenuation caused by the body of the mouse, the syringe
wasplaced inside a 2.5cm diameter plexiglass phantom ﬁlled
with water.
2.2. Phantom Measurements. A phantom containing a range
of activity concentrations was prepared using three 250μL
microcentrifuge tubes. The tubes were completely ﬁlled with
a total activity of 20MBq, 10MBq (In-111) or 5MBq (Tc-
99m), and 1MBq of either In-111 or Tc-99m in a volume of
250μL and inserted into a homemade polystyrene support
(Figure 1). The radionuclides used for the phantom studies
were taken from the same batch of solution used for the
calibration. Each tube was weighed before and after additionInternational Journal of Molecular Imaging 3
of the radionuclide to determine the exact volume present.
The radioactivity present in each microcentrifuge tube was
calculated by weight based on the measured concentration in
the calibration syringe.
For the In-111 studies, the phantom was imaged every
day for 11 days until the activity present in the low activity
microcentrifuge tubes had decayed through approximately 4
half-lives. For the Tc-99m studies, the phantom was imaged
at intervals for 2 days (8 half-lives).
Circular CT scans were acquired in 180 projections,
at 45kVp with 1000ms exposure time and 3 minute scan
duration. The scan range was 26mm. Helical SPECT scans
were acquired with either 30 seconds or 120 seconds per
projection frame resulting in acquisition times of either 5
or 20 minutes. Each scan was repeated 4 times to test the
reproducibility of the system.
2.3. Attenuation Measurements. The attenuation of the
phantom versus the syringe used to calibrate the camera
was investigated to see how it aﬀected the accuracy of
quantifying the image data. This was achieved by measuring
weighed amounts (20MBq) of isotope into either a syringe
(1.5mL) or a microcentrifuge tube (250μL). The activity
present in each was measured using the dose calibrator.
The syringe (inside the plexiglass attenuation phantom) and
microcentrifuge tube were individually imaged using the
same acquisition settings for ten minutes. The resultant ﬁles
were then reconstructed using the same parameters as the
phantom studies and the quantiﬁcation results were com-
pared. The percentage diﬀerence between the two methods
was recorded.
2.4.AnimalStudies(ImagingandBiodistribution). Allanimal
studies were performed in accordance with British Home
Oﬃce regulations governing animal experimentation and
Advisory Committee for Dangerous Pathogens guidelines in
a level 2 containment facility. 5 × 106 A431 cells, transfected
with CC-K2 receptors, were injected into the shoulders of
26 female immunodeﬁcient beige SCID mice (Charles River,
UK) and allowed to develop into tumours of approximately
5–10mm in diameter for use in imaging and biodistribution
studies.
10 days after injection, the mice were injected intra-
venously in the tail with 1 of 12 diﬀerent In-111-labelled
compounds (n = 2/3 per condition). Approximately 11–
18MBq in 200μL was injected into each mouse. Each
injected compound was a peptide with diﬀerent aﬃnities for
the CCK-2 receptor expressed by the tumours [13]. The dif-
ferent biodistribution pattern for each compound resulted in
a range of uptake values per gram of organ, therefore testing
the limits of the quantiﬁcation accuracy of the camera.
At 4 hours after injection, the mice were anaesthetised
with 2% isoﬂurane gas and 0.5L/min oxygen and imaged
using the NanoSPECT/CT camera. The animals were kept
warm throughout the acquisition using a heated bed system
(Minerve,France).WholebodySPECTimageswereacquired
in 20 projections over 45 minutes using the 2mm pinhole
collimators, as indicated by the phantom studies. CT images
were acquired with a 45kVp tube voltage in 190 projections
over 6 minutes. Images were reconstructed using the same
reconstruction parameters as the phantom studies.
Postimaging the mice were culled by cervical dislo-
cation, and the tumour and kidneys were harvested for
quantiﬁcation analysis. Standards were prepared from a
sample of the original injected material and each tissue
sample was weighed and counted in a gamma-counter (LKB
Compugamma) along with the standards. The percentage
injected dose per organ and gram of tissue was determined
for each tissue type.
2.5. Image Reconstruction and Statistical Analysis. All SPECT
s c a n sw e r er e c o n s t r u c t e di na2 5 6× 256 matrix using
HiSPECT (Scivis GmbH, Germany) software. The same
reconstruction parameters were applied for all datasets: 35%
Gaussian ﬁltering, 9 iterations with a voxel size of 0.4mm.
Image reconstructions were carried out both with and
withouta“preclean”backgroundcorrectionoptionprovided
by the manufacturer. This consists of an algorithm designed
to remove isolated single counts from pixels for which the
neighbouring pixels contain no counts.
All images were analysed and fused with the CT image
using InVivoScope, proprietary Bioscan software. For the
phantom studies, a three-dimensional VOI was deﬁned
around each tube using the CT image as a reference and the
activity present in megabecquerels was calculated. The same
VOI was used for all subsequent phantom image analyses.
For the animal studies, the uptake in the tumour and
kidneys was also quantiﬁed using three-dimensional VOIs
and the CT as a guide. For tumours with irregular shapes,
multiple VOIs were created and the activities were summed
together. The percentage injected dose per organ and gram
was calculated using the weight of the tissue obtained after
dissection. These results were then correlated with the results
of the biodistribution study to determine the accuracy of
the SPECT camera. All measured activities were corrected
for decay and were compared to the true activity. Statistical
analysis was calculated using linear regression analysis using
the GraphPad PRISM analysis program.
3. Results
3.1. Phantom Studies. Reconstructed image slices (sagittal,
coronal and transversal) of the phantom are shown in
Figure 1 with the deﬁned volume-of-interest highlighted in
green. The sum of the activity (total activity) in all slices of
the tubes was selected for the quantiﬁcation measurements.
The average uptake of four scans for each condition was
calculated and used for analysis. We found the system to
be reproducible with a coeﬃcient of variation below 1% for
activities higher than 0.5MBq and below 4% for activities
lower than 0.5MBq.
Initially after reconstructing and quantifying the Tc-99m
data with the “preclean background subtraction” included,
a signiﬁcant negative bias was observed at low levels of
radioactivity. This was more pronounced for the scans with
the shorter frame time. For example, the deviation from
true values was within 10% for activities above 0.2MBq.
Below this, the deviation grew signiﬁcantly to approximately4 International Journal of Molecular Imaging
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Figure 2: Plot of % deviation of measured activity values from true activity values with Tc-99m using the 1.4mm pinhole apertures. Each
graph represents the full range of activity values measured for all 3 microcentrifuge tubes. The negative bias at low activities introduced by
background subtraction is clear in (a) and (c). This bias is eliminated for short and long frame times without any background removal, (b)
a n d( d ) ,r e s p e c t i v e l y .
82% for 0.03MBq using the longer frame time. However,
with the shorter frame time the deviation with 0.2MBq in
the phantom was almost 70% and with activities as low
as 0.035MBq the deviation was 100%. Figures 2(a)–2(d)
illustrate the percentage deviation of the measured SPECT
data from the true activity in the phantom over a large range
of activity using Tc-99m and the 1.4mm pinhole apertures.
It is clear from Figures 2(a) and 2(c) that there is a signiﬁcant
negativebiasatlowactivitieswithalargedeviationfromtrue
values(P<. 001for30sframesandP<. 01for120sframes).
The reconstructions were repeated without the default
“preclean” subtraction switched on. A marked diﬀerence in
results was observed. These are shown in Figures 2(b) and
2(d) which represent acquisitions with 30-second or 120-
second frame, respectively. With the background correction
removed during the reconstruction this negative bias is
eliminated and there is no signiﬁcant deviation from true
activity over the whole activity range. The results are also
comparable for both the short and long frame times.
For both frame times, the observed deviation from the
theoretical value for the total activity was consistent over the
range of activities imaged. The 120s frame time activities
were within 4% of reference whilst the 30s frame activities
were within 10%.
The In-111 phantom results for this aperture pinhole
size also showed a signiﬁcant negative bias at low activities
with the background subtraction on (P<. 01). This major
negative bias was eliminated after removing the background
subtraction; however, the percentage deviation from true
activity was still signiﬁcant even with the background
subtraction switched oﬀ during reconstruction. As a result,
acquisitions and quantiﬁcation with In-111 using larger
pinhole(2mm)apertureswereperformedtoseeifthiswould
improve the results due to the higher sensitivity and ensuing
increased count rates of these pinholes.
Figures 3(a)–3(d) show the results obtained using In-111
with the 2mm pinhole apertures. Once more, a signiﬁcant
deviation from true activity was found when the background
was subtracted during the reconstruction for the 30 second
frame time but interestingly not for the 120-second frame
time where even with the background correction switched
on there was no signiﬁcant deviation from true activity over
the range of activities. For the scans without background
removal there was no signiﬁcant deviation from true activity
values with either the short or the long frame time. For
both frame times with the subtraction oﬀ, there was a range
in deviation of ≤12% across the entire range of activity
values, the lowest being approximately 0.087MBq. It shouldInternational Journal of Molecular Imaging 5
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Figure 3: Plot of % deviation of measured activity values from true activity values with In-111 using the 2mm pinhole apertures. Each
graph represents the full range of activity values measured for all 3 microcentrifuge tubes. The negative bias at low activities introduced by
background subtraction is also evident for short frame times in (a) whereas in (c) there is no signiﬁcant deviation due to the longer frame
time with a higher number of counts collected. This bias is eliminated for short and long frame times without any background removal,
(b) and (d), respectively. An oﬀset of approximately 8–10% exists due to attenuation diﬀerences between measurements of the calibration
syringe and the samples.
be noted, however, that the percentage deviation while
constant over the range of activities did display an oﬀset of
approximately 11%, that is, the deviation was consistently
overestimated regardless of scan duration. This is in contrast
with the Tc-99m results where the percentage deviation was
close to zero.
3.2.AttenuationMeasurements. Toinvestigatethisoﬀsetseen
in the In-111 studies, the attenuation of the calibration
syringe and the phantom tubes were compared as detailed
in the methods section. The diﬀerence in absolute quantiﬁ-
cation of the radioactivity in the phantom tube compared to
the calibration syringe was 7.8%.
3.3. Animal Studies. All compounds showed uptake in the
tumour and kidneys of the injected mice; an example image
is shown in Figure 4. The absolute activity present in the
organs was calculated from the NanoSPECT/CT data by
drawing VOIs using the CT as a reference. After necropsy
andcountingoftissuesamples,thepercentageoftheinjected
dose in the tumour and kidney tissues was determined at 4
hours after injection for each mouse (n = 26). The uptake
values ranged from 0.5–8.4%ID for the tumours and 0.1–
93%IDforthekidneys,resultinginverylowabsolutelevelsof
activity in some of the tumour samples, as little as 0.02MBq.
The results from the necropsy and imaging data sets were
then compared. As shown in Figure 5, there is a highly
signiﬁcant correlation between the biodistribution data and
the NanoSPECT/CT acquired data for both the tumour (a)
and kidneys (b). Linear regression analysis conﬁrmed these
observations with r2 ≥ 0.8174 for the tumour measurements
and r2 ≥ 0.9953 and for the kidney measurements.
4. Discussion
We have demonstrated that, once the automatic background
subtraction feature of the software was disabled, consis-
tent quantiﬁcation of low activities is feasible with the
NanoSPECT/CT preclinical imaging system. It is known that
removalofcountsfromtheacquiredprojectiondatacanlead
to non-Poisson statistics [14]. Under these circumstances,6 International Journal of Molecular Imaging
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Figure 4: Representative NanoSPECT/CT image of 1 compound
showing the tumour and kidney uptake at 4 hours after injection.
the OSEM algorithm which is based upon an assumption of
Poisson statistics in the acquired data will become increas-
ingly biased with respect to the quantitation of radioac-
tivity. Furthermore, as the counts acquired are reduced,
the background algorithm would seem to be increasingly
likely to remove counts originating from the distribution of
radiopharmaceutical within the animal/phantom itself.
Although our results demonstrate errors of <12% in
absolute quantitation, in particular with regards to In-111,
it is important to note that this deviation is consistent over
the range of activities imaged.
In addition, we expanded on our phantom results by
performing animal imaging experiments which yielded an
excellent correlation with ex vivo measurements. The frame
times used were as short as 30 seconds resulting in a total
scan time of 5 minutes with activities as low as 136kBq/mL,
thereby simulating typical tumour tissue uptake concentra-
tions. This enables us to validate the quantiﬁcation of animal
studies even in situations where the uptake in a target organ
is relatively low.
For the In-111 studies, a decrease in pinhole size resulted
in increased deviation which was signiﬁcantly diﬀerent from
the true values. A reason for this discrepancy with In-111
could be because the count rate for In-111 was not as high as
with Tc-99m since, due to the higher energy of this isotope
the sensitivity of this detector is greater for Tc-99m than for
In-111. This inferior count rate will lead to poorer statistics
during the reconstruction process and lead to more errors
in quantiﬁcation calculation. A similar pattern of results was
observed as with the Tc-99m data but the quantiﬁcation
deviation was higher with the In-111 phantoms. To address
this, the phantom study was repeated using 2mm pinhole
apertures. The results of the In-111 experiment with the
2mm pinholes showed improved correlation. No signiﬁcant
deviation from true activity over the entire range of activities
measured was observed, and no diﬀerence in deviation
for the diﬀerent frame times was found, even at very low
activities. This is likely to be because the larger pinhole size
results in an increased sensitivity and higher count rates
meaning that scan times can be shorter that those required
for smaller pinholes. The reason why there was no signiﬁcant
deviation between the measured and true values for the
longer frame time even with the background subtraction
switched on is likely to be because of the acquisition of larger
number of counts in the image.
A sc a nb es e e ni nFigure 3, there was a consistent oﬀset
for the In-111 phantom studies for both sets of apertures.
The oﬀset was approximately 8–11% from true values and
was apparent even at high activities. This oﬀset was therefore
constant over all activity ranges and frame durations. The
oﬀset was also present with the background subtraction
either switched on or disabled during the reconstruction.
There could be two reasons for this oﬀset. Firstly, this
could be a systematic error introduced during the initial
dispensing of activity. This is especially relevant for the
1MBq tube which had a higher oﬀset, as there can be greater
uncertainty when measuring out smaller volumes. In fact,
this explanation is unlikely as the volumes dispensed were
accurately weighed into the phantom tubes to ensure that
the exact volume was present. Alternatively, the oﬀset for
the In-111 measurement may be due to attenuation dif-
ferences between the calibration syringe measurements and
those of the microcentrifuge tubes. When the camera was
calibrated, the syringe was inserted into a 2.5cm diameter
plexiglass phantom to mimic the attenuation of a mouse.
However, the microcentrifuge tubes used for the phantom
imaging experiments were imaged without such a device
and consequently present only a very thin layer of plastic
(∼0.5mm) to attenuate the electrons and photons emitted
by the radionuclide. It was thought likely that this diﬀerence
in attenuation of the two types of plastic containers could
account for the consistent overestimation of activity values
for the phantom studies. After imaging both types of plastic
containers containing exactly the same amount activity, a
diﬀerence of 7.8% was found between the two indicating
that attenuation is likely to be the cause of the oﬀset for the
In-111 studies. Of note is the fact that this overestimation
was not observed during the animal studies, strengthening
the hypothesis that this oﬀset was due to diﬀerences in the
attenuation by the syringe and plexiglass phantoms and that
this calibration phantom is a good device for mimicking the
attenuation of a mouse.
For all the In-111 acquisitions for each pinhole size, the
number of counts emitted from each tube in the phantom
each day was recorded. This data was normalised for frame
time and plotted against the equivalent percentage deviation
to determine the optimal total count rate per frame for
accurately quantiﬁable data (see Figure 6).
It can be seen that a minimum of 10,000 counts per
frame is required to obtain data that is within 10% of the
true activity values when background subtraction is applied.
Lower count rates per frame than this will be prone to higher
levels of deviation from true activity. With no background
subtraction, the percentage deviation was approximately
9.4% with acquisitions of 9,000 total counts per frame andInternational Journal of Molecular Imaging 7
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Figure 5: Correlation between SPECT measured results in MBq and ex vivo % ID measured in the gamma counter for tumours (a) and
kidneys (b). There is a statistically signiﬁcant correlation between the SPECT data and the biodistribution data which conﬁrms the phantom
results that the quantiﬁcation is reliable at low activities.
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Figure 6: The count rate per second for each activity concentration
as a product of frame time (30s or 120s) was plotted against the %
deviation to determine the optimal total count rate per frame for
accurately quantiﬁable data.
0.5% with 100,000 total counts per frame when using In-
111. Since the count rate, or number of counts per second,
is dependent on the activity of the source and the sensitivity
of the camera, the frame time can be varied accordingly by
the user to achieve a certain total number of counts and,
therefore, quantiﬁable data. This can be used as a guideline
for planning future imaging studies in terms of the activity
and the scan times required per animal.
Although the results of the phantom studies indicate
that the quantiﬁcation performed with the NanoSPECT/CT
scanner is accurate, results obtained from animal studies
represent a situation closer to that pertaining to real life.
The results from the animal data indicate that there is a
highly signiﬁcant correlation between the measured SPECT
data and the ex vivo biodistribution data and suggest
that results obtained by imaging can potentially replace
those obtained from dissection and counting studies. This
allows the kinetics and biodistribution of radiotracers to be
determined over time in the same animal in longitudinal
studieswhichenablesfeweranimalstobesacriﬁcedtoobtain
the same information. The results of the diﬀerent frame time
analyses are also promising because they show that accurate
quantiﬁcation of dynamic imaging of mice using short scan
t i m e si sa c h i e v a b l e .
One of the limitations of our paper is that it only
addresses quantitation of activity in mice using either
Tc-99m or In-111. We did not explore the accuracy of
measurements in larger animals such as rats or lower energy
isotopes such as I-125. In both of these situations, the eﬀect
of attenuation will become more signiﬁcant. For example,
in simulations of preclinical imaging without attenuation
correction, Chen et al. [15] calculated that imaging of I-
125 would result in a deviation of up to 40% from the
true activity and Hwang and Hasegawa [16]s i m u l a t e da
50% reduction in measured activity using I-125 in a rat-
sized water phantom which was later conﬁrmed in animal
experiments. The emitted low-energy photons (27–35keV)
are more strongly attenuated than with Tc-99m [17]. Wu
et al. [18] calculated an underestimation of 10–30% in Tc-
99m activity concentration of phantom and rats in studies
without attenuation and scatter correction applied. These
errors were reduced to −6 to +4% after these corrections
were applied. Although we have shown that calibration using
an appropriate phantom can correct for the lower levels of
attenuation caused by the mouse body when radionuclides
of medium-higher energies are used, this may not be the case
when either larger animals or lower energy radionuclides are
employed.
5. Conclusion
We found that once the automatic background feature of
this iterative OSEM algorithm used to implement image
reconstruction in this multi-pinhole preclinical SPECT cam-
era was disabled, it resulted in consistent quantitation of8 International Journal of Molecular Imaging
Tc-99m and In-111 over a range of activities and imaging
times. The use of an appropriate calibration phantom
meant that absolute errors were within 12% of the true
activity. Furthermore a comparison of in vivo imaging and
biodistribution showed a correlation of 0.99 for activities
over the 200kBq to 5MBq range.
We conclude that the quantitative information provided
by the NanoSPECT imager is suﬃciently accurate and
reproducible to allow replacement of some dissection studies
for assessment of radiotracer biodistribution.
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